Your browser is no longer supported. Please, upgrade your browser.
KRTX Karuna Therapeutics, Inc. monthly Stock Chart
KRTX [NASD]
Karuna Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.67 Insider Own13.20% Shs Outstand26.19M Perf Week6.59%
Market Cap2.13B Forward P/E- EPS next Y-3.96 Insider Trans-39.89% Shs Float22.74M Perf Month1.54%
Income-42.50M PEG- EPS next Q-0.82 Inst Own85.50% Short Float6.84% Perf Quarter-2.28%
Sales- P/S- EPS this Y-106.20% Inst Trans1.96% Short Ratio9.31 Perf Half Y-3.48%
Book/sh14.20 P/B5.65 EPS next Y-39.90% ROA-12.80% Target Price125.90 Perf Year527.96%
Cash/sh13.87 P/C5.78 EPS next 5Y- ROE-13.00% 52W Range12.48 - 152.00 Perf YTD6.44%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-47.24% Beta-
Dividend %- Quick Ratio92.10 Sales past 5Y- Gross Margin- 52W Low542.55% ATR3.44
Employees19 Current Ratio92.10 Sales Q/Q- Oper. Margin- RSI (14)53.38 Volatility4.95% 4.39%
OptionableYes Debt/Eq0.00 EPS Q/Q-0.70% Profit Margin- Rel Volume0.57 Prev Close82.50
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume167.10K Price80.19
Recom1.50 SMA201.77% SMA501.77% SMA200-6.52% Volume95,632 Change-2.80%
Aug-06-20Reiterated H.C. Wainwright Buy $140 → $130
May-28-20Initiated H.C. Wainwright Buy $140
Apr-28-20Initiated Oppenheimer Outperform $125
Mar-31-20Initiated Guggenheim Buy $120
Mar-24-20Resumed Wedbush Outperform $124
Feb-06-20Initiated Mizuho Buy
Jan-09-20Initiated JMP Securities Mkt Outperform $122
Dec-19-19Initiated Stifel Buy $126
Dec-12-19Initiated William Blair Outperform $105
Jul-23-19Initiated Wells Fargo Outperform $29
Jul-23-19Initiated Wedbush Outperform $38
Jul-23-19Initiated Goldman Buy $34
Jul-23-19Initiated Citigroup Buy $28
Oct-26-20 09:51AM  
Sep-22-20 10:22AM  
Sep-21-20 09:56AM  
Sep-03-20 06:30AM  
Aug-17-20 11:46AM  
Aug-13-20 06:30AM  
Aug-05-20 06:00AM  
Aug-03-20 04:30PM  
Jul-30-20 06:30AM  
Jul-28-20 06:30AM  
Jun-28-20 07:14PM  
Jun-24-20 08:56AM  
Jun-23-20 06:30AM  
Jun-03-20 06:30AM  
May-27-20 06:30AM  
May-20-20 09:17AM  
08:48AM  
May-07-20 06:00AM  
Apr-28-20 06:00AM  
Apr-27-20 10:09AM  
Apr-22-20 10:55AM  
Apr-07-20 05:18PM  
Mar-31-20 08:35AM  
Mar-26-20 07:00AM  
Mar-24-20 06:00AM  
Feb-25-20 07:00AM  
Feb-06-20 07:00AM  
Jan-12-20 02:36PM  
Jan-09-20 08:00AM  
Dec-27-19 09:17AM  
Dec-26-19 09:53AM  
Dec-23-19 02:47PM  
Dec-20-19 12:38PM  
Dec-19-19 09:53PM  
Dec-10-19 03:17AM  
Nov-26-19 07:00AM  
07:00AM  
Nov-20-19 06:58PM  
09:31AM  
Nov-19-19 04:20PM  
09:54AM  
07:56AM  
05:51AM  
Nov-18-19 04:21PM  
11:18AM  
06:00AM  
Nov-17-19 04:00PM  
Nov-07-19 06:00AM  
Aug-28-19 08:00AM  
Aug-08-19 06:00AM  
Aug-06-19 08:00AM  
Jul-02-19 07:15PM  
04:01PM  
Jun-28-19 11:32AM  
Jun-27-19 05:44PM  
04:37PM  
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric disorders and pain. Its lead product candidate is KarXT, an oral modulator that has completed Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia; and in Phase Ib clinical trial for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, Alzheimer's, and pain, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Miller Andrew CraigChief Operating OfficerOct 12Option Exercise7.275,00036,35038,000Oct 13 05:15 PM
Miller Andrew CraigChief Operating OfficerOct 12Sale78.675,000393,35033,000Oct 13 05:15 PM
Pande AtulDirectorSep 16Option Exercise2.925,00014,6005,000Sep 18 04:09 PM
Pande AtulDirectorSep 16Sale85.005,000425,0000Sep 18 04:09 PM
Miller Andrew CraigChief Operating OfficerSep 10Option Exercise7.275,00036,35038,000Sep 10 05:18 PM
Miller Andrew CraigChief Operating OfficerSep 10Sale75.525,000377,60033,000Sep 10 05:18 PM
HEALY JAMESDirectorSep 09Buy73.754,557336,0791,952,441Sep 11 10:22 AM
Ignelzi Troy A.Chief Financial OfficerSep 08Option Exercise9.202,00018,4007,000Sep 10 05:15 PM
HEALY JAMESDirectorSep 08Buy73.0050436,7921,947,884Sep 09 05:04 PM
Ignelzi Troy A.Chief Financial OfficerSep 08Sale73.302,000146,6005,000Sep 10 05:15 PM
Preston HeatherDirectorSep 04Buy72.3635025,3265,800Sep 09 08:10 PM
HEALY JAMESDirectorSep 04Buy71.7361,7784,431,1161,947,380Sep 09 05:04 PM
PureTech Health LLC10% OwnerAug 26Sale76.211,333,333101,616,2413,406,564Aug 26 05:15 PM
Ignelzi Troy A.Chief Financial OfficerAug 25Option Exercise9.205,00046,0005,000Aug 27 05:58 PM
Pande AtulDirectorAug 12Option Exercise2.925,00014,6005,000Aug 14 04:16 PM
Pande AtulDirectorAug 12Option Exercise2.925,00014,6005,000Aug 14 04:19 PM
Pande AtulDirectorAug 12Sale85.005,000425,0000Aug 14 04:16 PM
Pande AtulDirectorAug 12Sale85.005,000425,0000Aug 14 04:19 PM
HARRIGAN EDMUNDDirectorAug 12Sale83.3210,000833,20055,163Aug 14 04:13 PM
Pande AtulDirectorJul 13Option Exercise2.925,00014,6005,000Jul 13 04:49 PM
Pande AtulDirectorJul 13Sale95.435,000477,1500Jul 13 04:49 PM
HARRIGAN EDMUNDDirectorJul 13Sale93.4010,000934,00065,163Jul 13 04:48 PM
Ignelzi Troy A.Chief Financial OfficerJul 08Option Exercise9.208,00073,6008,000Jul 10 09:21 PM
Ignelzi Troy A.Chief Financial OfficerJul 08Sale98.748,000789,9200Jul 10 09:21 PM
Brannan Stephen K.Chief Medical OfficerJul 01Option Exercise8.2810,22884,72322,728Jul 02 04:03 PM
Brannan Stephen K.Chief Medical OfficerJul 01Sale108.537,728838,72015,000Jul 02 04:03 PM
PAUL STEVEN MPRESIDENT & CEOJun 29Option Exercise0.11292,20732,143398,692Jun 30 04:25 PM
PAUL STEVEN MPRESIDENT & CEOJun 29Sale103.50292,20730,243,425106,485Jun 30 04:25 PM
Miller Andrew CraigChief Operating OfficerJun 16Option Exercise9.208,33476,67341,334Jun 16 05:00 PM
Ignelzi Troy A.Chief Financial OfficerJun 16Option Exercise9.202,00018,4002,000Jun 17 04:40 PM
Ignelzi Troy A.Chief Financial OfficerJun 16Sale100.002,000200,0000Jun 17 04:40 PM
Miller Andrew CraigChief Operating OfficerJun 16Sale97.588,334813,23233,000Jun 16 05:00 PM
Miller Andrew CraigChief Operating OfficerJun 15Option Exercise4.0241,333166,13237,762Jun 16 05:00 PM
Ignelzi Troy A.Chief Financial OfficerJun 15Option Exercise9.206,00055,2004,000Jun 17 04:40 PM
Ignelzi Troy A.Chief Financial OfficerJun 15Sale89.756,000538,4800Jun 17 04:40 PM
Miller Andrew CraigChief Operating OfficerJun 15Sale92.388,333769,80333,000Jun 16 05:00 PM
Miller Andrew CraigChief Operating OfficerJun 12Option Exercise8.058,33367,07537,968Jun 16 05:00 PM
Pande AtulDirectorJun 12Option Exercise2.925,00014,6005,000Jun 15 05:19 PM
HARRIGAN EDMUNDDirectorJun 12Sale91.7930,0002,753,70075,163Jun 15 05:20 PM
Pande AtulDirectorJun 12Sale93.275,000466,3500Jun 15 05:19 PM
Miller Andrew CraigChief Operating OfficerJun 12Sale93.288,333777,30233,000Jun 16 05:00 PM
Miller Andrew CraigChief Operating OfficerJun 01Option Exercise7.2725,000181,75025,000Jun 02 04:34 PM
Brannan Stephen K.Chief Medical OfficerJun 01Option Exercise6.8310,22869,80820,228Jun 02 04:35 PM
Brannan Stephen K.Chief Medical OfficerJun 01Sale90.647,728700,46612,500Jun 02 04:35 PM
Miller Andrew CraigChief Operating OfficerJun 01Sale90.6425,0002,266,0000Jun 02 04:34 PM
PureTech Health LLC10% OwnerMay 22Sale81.03555,50045,014,7504,739,897May 26 06:05 AM
Ignelzi Troy A.Chief Financial OfficerMay 08Option Exercise9.207,50069,0007,500May 12 04:33 PM
Ignelzi Troy A.Chief Financial OfficerMay 08Sale83.387,500625,3500May 12 04:33 PM
Brannan Stephen K.Chief Medical OfficerMay 01Option Exercise5.4510,22855,74317,728May 04 04:33 PM
Miller Andrew CraigChief Operating OfficerMay 01Option Exercise7.2725,000181,75025,000May 04 04:32 PM
Miller Andrew CraigChief Operating OfficerMay 01Sale76.9825,0001,924,5000May 04 04:32 PM
Brannan Stephen K.Chief Medical OfficerMay 01Sale79.387,728613,44910,000May 04 04:33 PM
Brannan Stephen K.Chief Medical OfficerApr 01Option Exercise8.2810,22884,72315,228Apr 03 05:06 PM
Miller Andrew CraigChief Operating OfficerApr 01Option Exercise5.4225,000135,40514,346Apr 03 05:07 PM
Miller Andrew CraigChief Operating OfficerApr 01Sale64.3725,0001,609,2500Apr 03 05:07 PM
Brannan Stephen K.Chief Medical OfficerApr 01Sale67.367,728520,5587,500Apr 03 05:06 PM
Preston HeatherDirectorMar 12Buy71.712,050146,9985,450Mar 12 06:34 PM
Preston HeatherDirectorMar 10Buy80.001,00080,0003,400Mar 12 06:34 PM
Miller Andrew CraigChief Operating OfficerMar 02Option Exercise2.9225,00073,00017,857Mar 04 04:35 PM
Brannan Stephen K.Chief Medical OfficerMar 02Option Exercise6.8310,22869,80812,728Mar 04 04:38 PM
Ignelzi Troy A.Chief Financial OfficerMar 02Option Exercise9.207,50069,0007,500Mar 04 04:42 PM
Brannan Stephen K.Chief Medical OfficerMar 02Sale86.557,728668,8585,000Mar 04 04:38 PM
Ignelzi Troy A.Chief Financial OfficerMar 02Sale86.507,500648,7500Mar 04 04:42 PM
Miller Andrew CraigChief Operating OfficerMar 02Sale86.6125,0002,165,2500Mar 04 04:35 PM
Brannan Stephen K.Chief Medical OfficerFeb 19Option Exercise5.4510,22855,74310,228Feb 20 04:25 PM
Brannan Stephen K.Chief Medical OfficerFeb 19Sale101.637,728785,3972,500Feb 20 04:25 PM
PureTech Health LLC10% OwnerJan 22Sale95.672,100,000200,907,0005,295,397Jan 24 04:40 PM
Preston HeatherDirectorJan 09Buy70.5078855,5542,400Jan 10 04:48 PM
Preston HeatherDirectorJan 03Buy69.801,42799,6011,612Jan 07 06:09 PM
Preston HeatherDirectorDec 31Buy70.0018512,950185Jan 03 05:13 PM
HEALY JAMESDirectorNov 25Buy96.00156,25015,000,0001,885,602Nov 25 09:38 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.